Generics - Equal or not?

    Research output: Contribution to journalComment/debate

    73 Citations (Scopus)

    Abstract

    Generic products must be bioequivalent to the innovator brand before they can be marketed in Australia. There are no generic formulations of drugs with a narrow therapeutic index as it would be difficult for them to meet the required standard of bioequivalence. In Australia most generic drugs are marketed with a brand name. Some generic brands are manufactured by the same company that produces the innovator brand of the drug. Although generic brands are usually cheaper the proliferation of brands may cause confusion.

    Original languageEnglish
    Pages (from-to)85-87
    Number of pages3
    JournalAustralian Prescriber
    Volume26
    Issue number4
    DOIs
    Publication statusPublished - 1 Aug 2003

    Keywords

    • Bioequivalence
    • Drug regulation
    • Pharmaceutical industry

    Fingerprint Dive into the research topics of 'Generics - Equal or not?'. Together they form a unique fingerprint.

  • Cite this